103 results
Page 3 of 6
8-K
EX-99.1
2kd08ihyhskhjka22u
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
EX-99.1
tn0r1dt
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
8-K
EX-10.1
fre3yzsaigsnw3u3
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-99.1
k2lzxzhn 2hge508u
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
msu sgkpfsm
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
424B5
3l8sk4fctl7
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
mgewne2 0c4l9i0xcp
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
38euqsv5o6x 8ib4eh7
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.2
ssaxpkmdf0 oz
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.1
ivlgxro3
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
6uoppti848
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
EX-99.1
0l1j2sw7
10 Jan 20
Regulation FD Disclosure
5:16pm
8-K
EX-99.1
t0a07sr djdboa
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
424B5
9fdr9
25 Oct 19
Prospectus supplement for primary offering
12:00am